Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how OptiBiotix Health Plc turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2012 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $457,000 | $2.21M | $1.52M | $514,289 | $191,073 | $288,119 | $28,200 | $0 | $161,597 | $0 |
| Revenue Growth? | -79.3% | +45.3% | +196.2% | +169.2% | -33.7% | +921.7% | 0.0% | -100.0% | 0.0% | 0.0% |
| Cost of Revenue? | $213,000 | $1.09M | $643,428 | $162,782 | $73,706 | $38,214 | $0 | $0 | $257,193 | $0 |
| Gross Profit? | $244,000 | $1.12M | $879,819 | $351,507 | $117,367 | $249,905 | $28,200 | $0 | -$95,596 | $0 |
| Gross Margin? | +53.4% | +50.8% | +57.8% | +68.3% | +61.4% | +86.7% | +100.0% | 0.0% | -59.2% | 0.0% |
| Operating Expenses? | $10.76M | $2.49M | $1.99M | $1.85M | $2.24M | $1.77M | $1.45M | $854,053 | $1.55M | $39,000 |
| Operating Income? | -$2.49M | -$1.37M | -$1.11M | -$1.50M | -$2.13M | -$1.52M | -$1.42M | -$489,015 | -$1.65M | -$39,000 |
| EBITDA? | -$10.38M | $6.51M | $6.00M | -$1.81M | -$2.42M | -$1.52M | -$1.31M | -$853,809 | -$1.65M | -$39,000 |
| Income Before Tax | $2.44M | $6.18M | $5.71M | -$1.95M | $1.69M | -$1.52M | -$1.42M | -$853,960 | -$1.65M | -$37,000 |
| Income Tax Expense | -$146,000 | -$84,523 | -$91,635 | -$54,371 | -$228,447 | -$174,544 | -$142,594 | -$43,254 | -$5,326 | -$1,000 |
| Net Income? | $2.59M | $6.26M | $5.80M | -$1.92M | $1.91M | -$1.30M | -$1.28M | -$810,706 | -$1.65M | -$36,000 |
| EPS? | $0.03 | $0.07 | $0.07 | $-0.02 | $0.02 | $-0.02 | $-0.02 | $-0.03 | $-8.78 | $-4.53 |
| Diluted EPS? | $0.03 | $0.07 | $0.06 | $-0.02 | $0.02 | $-0.02 | $-0.02 | $-0.03 | $-8.78 | $-4.53 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality